Seagen Inc.
(NASDAQ : SGEN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -1.20%349.340.0%$6647.20m
BNTXBioNTech SE 3.99%341.460.0%$1136.65m
SNSSSunesis Pharmaceuticals, Inc. 3.42%10.880.7%$760.55m
NVAXNovavax, Inc. 3.53%185.6779.8%$671.99m
AMGNAmgen, Inc. -0.58%240.131.3%$496.33m
BIIBBiogen, Inc. 1.66%332.161.7%$438.42m
VRTXVertex Pharmaceuticals, Inc. -1.71%198.141.9%$407.65m
GILDGilead Sciences, Inc. 0.03%68.311.0%$401.42m
REGNRegeneron Pharmaceuticals, Inc. 0.45%577.192.7%$355.48m
ILMNIllumina, Inc. -0.27%494.423.5%$263.30m
NTLAIntellia Therapeutics, Inc. -2.47%138.352.3%$257.39m
CRSPCRISPR Therapeutics AG 1.72%123.100.6%$147.21m
XBIOXenetic Biosciences, Inc. 24.82%5.080.0%$127.54m
EXASEXACT Sciences Corp. 1.66%109.6318.1%$125.64m
SGENSeagen Inc. 0.42%154.045.8%$120.74m

Company Profile

Seagen Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.